Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

The following is a summary of “Skin Microbiome in the First Year of Life and Its Association With Atopic Dermatitis,” ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Unspecified Respiratory Disorders.

Secukinumab is under clinical development by Novartis and currently in Phase II for Unspecified Dermatological Disorders.

FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.

Annual Meeting took place in Toronto, Canada, July 11-15, with our top coverage including the hot topics of combating ...

INR:3473. india cricket live streaming online Sanofi/Regeneron's Dupixent for the treatment of atopic dermatitis in children ...

INR:3193. odi world cup how many years once Innovative synthetic lethal therapy achieves first patient dosing, new company raises $75.2 million ...

INR:2567. in-play betting Amgen 2019 financial report: 6 new products emerge to take over the biosimilar drugs Sanofi/Regeneron Dupixent successfully treats sever ...

punjab state lottery bumper diwali Beware of monopoly! Pay attention to drug pricing behavior! 20 Municipal Medical Insurance ...

modern rummy download Big news! Hengrui stops developing a large number of generic drugs Once again surpassing the others, Fu Enhua Pharmaceutical's midazolam injection was approved and passed the ...